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Abstract The aim of this study was to determine the risk
and burden of vertebral fractures judged as those coming
to clinical attention and as morphometric fractures.
Incidence and utility loss were computed from data from
Malmo, Sweden. Clinical fractures accounted for 23% of
all vertebral deformities in women and for 42% in men.
The average 10-year fracture probability for morpho-
metric fractures increased with age in men from 2.9% at
the age of 50 years (7.2% in women) to 8.4 at the age of
85 years (26.7% in women). As expected, probabilities
increased with decreasing T-score for hip BMD. Cumu-
lative utility loss from a clinical vertebral fracture was
substantial and was 50–62% of that due to a hip fracture
depending on age. When incidence of fractures in the
population was weighted by disutility, all spine fractures
accounted for more morbidity than hip fracture up to the
age of 75 years.We conclude that vertebral fractures have
a major personal and societal impact that needs to be
recognised in algorithms for assessment of risk and in
health economic strategies for osteoporosis.
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Introduction
We have previously characterised the morbidity in the
population of Sweden that arises from osteoporotic
fractures. In that study fracture risk was weighted
according to the morbidity associated with each osteo-
porotic fracture [1]. The unit of morbidity used was the
cumulative loss of quality of life (disutility). The purpose
was to devise a methodology to compute intervention
thresholds where the multiple outcomes of different
fractures and the different consequenceswere reduced to a
single metric. Since then data have become available that
suggest that the incidence and consequences of vertebral
fracture may have been considerably underestimated.
Whereas our previous study focused on the probability
of a clinical vertebral fracture and its attendantmorbidity,
it is now evident that morphometric fractures that do
not come to clinical attention have significance, since
they are not all asymptomatic [2, 3]. Moreover, the risk
of further fractures is increased [4]. With respect to
clinical fractures, recent estimates suggest that the loss of
quality of life is very significant, and far greater than
hitherto appreciated [5, 6, 7, 8]. Indeed, the loss of quality
of life in the 1st year after clinical fracture may be of
the same order of magnitude as that for a hip fracture [9].
The aim of the present study was to determine the
risk of both morphometric and clinically diagnosed
fractures. For this purpose the first vertebral fracture
was documented so that 10-year probabilities of fracture
could be computed. A further aim was to characterise
the burden of both morphometric and clinical fractures
as judged by cumulative disutility.
Materials and methods
Incidence of vertebral fracture
Vertebral fractures may be clinically overt (i.e., coming to clinical
attention), clinically silent or asymptomatic. Collectively, they are
termed morphometric fractures. For the purposes of this paper we
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wished to estimate the incidence burden and long-term probability
of both morphometric fractures and clinical fractures. A clinical
fracture in this context is one that comes to hospital attention
through in-patient or outpatient attendance or one diagnosed
radiographically by the general practitioner.
For the incidence of clinically diagnosed vertebral fracture we
used data from Malmo 1993/1994 [10], and a Poisson model was
used to smooth the published function with age. For the incidence
of morphometric fractures we computed the incidence in Europe
from the EVOS/EPOS [11] and the Rotterdam study [12]. Both
studies measured morphometric deformities prospectively using an
identical algorithm [13]. A Poisson model was used to estimate the
incidence of morphometric fractures in the two studies. The un-
weighted b coefficients (i.e., unweighted by sample size) were used
to merge the data and compute the incidence in Europe. The
incidence was revised upward to take account of the higher age and
sex-specific incidence in Sweden compared with rates in Europe
[11]. For men, rates were multiplied by 1.28 and for women by
1.654. These estimates together with the disutility (see later) were
used to determine the burden of vertebral fractures at specific ages
in both men and women.
For the computation of the probability of a first vertebral
fracture, it was necessary to determine the incidence of a first ver-
tebral fracture. In the case of clinically diagnosed fractures, this has
previously been assessed directly from patients in Malmo [10] by
accessing the in-patient, out-patient and radiology records from
1993 and 1994. Patients with prior vertebral fractures were excluded
to compute incidence of a first vertebral fracture. The ratio of the
incidence of a first fracture to the unadjusted incidence of vertebral
fracture was 0.75 in men and 0.73 in women, and relatively constant
with age. In the Rotterdam study, the estimate is very similar for
morphometric fractures, being 0.79 in men and 0.69 in women [12].
For the present purposes we took the ratio of 0.74 and assumed that
the same ratio was also applicable to morphometric fractures. For
comparative purposes we used data on the incidence of hip and
other osteoporotic fractures from a previous publication [1].
Probability of fracture
The 10-year probability of vertebral fracture was calculated using a
Poisson model from the incidence of the first fracture with age and
the mortality estimates by age in 5-year intervals. Vertebral frac-
tures included those coming to clinical attention and all morpho-
metric fractures. The 10-year probabilities were computed by
previously published methods from the hazard of first fracture and
the death hazard [14, 15].
In order to determine the fracture probability according to
BMD, we used the published data from the 3rd National Health
and Nutrition Examination Survey (NHANES III, 1998–1994) as
the reference values for BMD at the femoral neck [16]. Cut off
values to categorize individuals as having low bone mass or
osteoporosis utilised the WHO criteria, so that osteoporosis was
defined as a T-score of <)2.5 SD and low bone mass denoted a
T-score of )1 to )2.5 SD [17]. Cut-off values were chosen in
young women based on the age range 20–29 years. The threshold
for low bone mass was 0.740 g/cm2 and 0.577 g/cm2 for osteo-
porosis. We chose the same thresholds for men since the incidence
of hip and vertebral fracture in men is similar to that in women
for the same BMD [18, 19, 20, 21, 22]. The risk of fracture at the
spine was assumed to increase 1.8-fold for each standard deviation
decrease in bone mineral density (95% CI 1.1–2.7), as estimated
by a previous meta-analysis [23]. Probability by age was expressed
as the risk of an individual at a given T-score for BMD [14].
Quality of life
Quality of life following a clinical vertebral fracture was taken from
a study in which this was assessed prospectively in 40 patients
attending the Accident and Emergency Department at Malmo
[7, 9]. The EQ-5D was administered at 14 days and 6, 9 and
12 months after the fracture event. Each patient was asked to fill in
the questionnaire on the health status experienced at the time of the
interview. Interviews were conducted in 43 patients at week 2, and
complete information obtained on 40 patients. The EQ-5D was
also administered to 86 patients with hip fracture, 126 patients with
a distal forearm fracture and 40 patients with a fracture at the
proximal humerus.
Health state values obtained from areas under the curve with
time did not differ between men and women, but decreased some-
what with age. Age and sex-specific social tariff values for Sweden
[24] were used to calculate the utility loss associated with each
fracture type. For a clinical vertebral fracture this was a loss of
0.260, which was greater than that for hip fracture (0.149), fracture
of the proximal humerus (0.153) and forearm fracture (0.017). Age
and specific utility losses were used to compute the multiplier that
could be used to determine utility losses for vertebral fracture and
other fracture types at any age (Table 1).
The utility losses for vertebral fracture obtained above
were those coming to clinical attention. The utility loss after a
morphometric deformity not coming to clinical attention is not
known. Patients with sub-clinical fracture are reported to have
impaired activities of daily living (ADLs) that are about one-third
to one-half of the ADLs in patients with a clinical fracture [2, 3].
On this basis we assumed that the utility loss of a sub-clinical
fracture was one-third that of a clinically overt fracture, since a
proportion of the decrement observed may have resulted
from co-morbidity. From the ratio of clinical to non-clinical frac-
tures (42% in men and 23% in women), the utility loss from all
vertebral fractures was calculated for the 1st year. In men, this was:
0:42 0:260ð Þ þ 0:58 0:260=3ð Þ ¼ 0:159 ð1Þ
This gave a multiplier of 0.777 in men for the 1st year.
In women, the utility loss in the 1st year was:
0:22 0:260ð Þ þ 0:78 0:260=3ð Þ ¼ 0:125 ð2Þ
This gave a multiplier of 0.820.
For the quality of life in the 2nd year after a clinical fracture we
used a multiplier of 0.909 (a utility loss of 0.100), calculated from a
case control study of patients enrolled into the MORE study with
vertebral fractures (both symptomatic and asymptomatic) [25].
Fracture occurred at an unknown time prior to assessment. The
value closely matches unpublished information from the CaMos
study in Canada (A Tenenhouse, personal communication, 2002).
We assumed that the utility loss in the 2nd year after a non-clinical
morphometric fracture was one-third that of a clinical fracture.
Thus, for the second year after a fracture (clinical and non-clinical)
the utility loss in men was:
0:42 0:1ð Þ þ 0:58 0:033ð Þ ¼ 0:061 ð3Þ
This gave a multiplier of 0.912.
Table 1 Health state utility values according to site of fracture
Fracture site Multiplier for
utility
Multiplier for
utility loss
1st
year
2nd
year
1st
year
2nd
year
Spine (clinical) 0.626 0.909 0.374 0.091
Spine (all morphometric)
men
0.777 0.912 0.223 0.088
Spine (all morphometric)
women
0.820 0.913 0.180 0.087
Ribs 0.977 0.999 0.003 0.001
Pelvis 0.794 0.815 0.206 0.185
Humerus 0.794 0.973 0.206 0.027
Clavicle, scapula, sternum 0.977 0.999 0.003 0.001
Hip 0.792 0.813 0.208 0.187
Other femoral 0.792 0.813 0.208 0.187
Tibia 0.794 0.926 0.206 0.074
Forearm 0.977 0.999 0.003 0.001
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In women the loss was:
0:22 0:1ð Þ þ 0:78 0:033ð Þ ¼ 0:048 ð4Þ
This gave a multiplier of 0.931 for the 2nd year in women.
For comparative purposes the utility loss for hip fracture, distal
forearm fracture and fractures of the proximal humerus were taken
from the study above. The utility loss after a rib, scapular, clavic-
ular and sternal fracture was assumed to be similar to that of a
distal forearm fracture [1, 26]. Femoral fractures other than the hip
had a loss equivalent to a hip fracture. For pelvic and leg fractures
the utility loss was equivalent to a humeral fracture as previously
assumed [1].
The quality of life in the 2nd year after a fracture varied
according to fracture type. For hip fracture this was assumed to be
90% of that of a healthy individual [27, 28], and the same
assumptions were used for other femoral fractures and for
pelvic fractures. For other sites of fracture, health state values
were assumed to improve after the 1st year by a proportion
equal to that previously assumed by the NOF [26] and by our-
selves [1]. Health state utility values are given in Table 1 for each
fracture site.
Burden of vertebral fracture
Loss of utilities after the 2nd and subsequent year were assumed to
decrease by 10% per year. The cumulative loss of utility (disutility)
was calculated for each age and fracture in men and women over
the remaining life-time. These disutilities were then weighted by the
social tariff values for each and sex and used to calculate the
incidence-adjusted morbidity, as previously described [1].
Results
Incidence of fracture
The incidence of all morphometric and clinical vertebral
fractures by age and sex is shown in Table 2. The ratio
of clinical to morphometric fractures was higher in men
than in women and in both sexes increased slightly with
age. Approximately 42% of vertebral fractures in men
came to clinical attention, and in women the proportion
was 22%.
Ten-year vertebral fracture probability
The average 10-year probability of morphometric and
clinical spine fractures is shown in Table 3. As expected,
probabilities of morphometric fractures were substan-
tially higher than for clinical fractures, and both increased
with age up to the age of 80 years. Thereafter, the 10-year
probability plateaued or decreased because of the
competing effects of fracture and death hazards. As
expected, probabilities were higher inwomen than inmen.
The probability of vertebral fracture by age, sex and
T-score is shown in Fig. 1. Fracture probabilities in-
creased with decreasing T-score and increasing age, up
to the age of 70 years. Above this age, probabilities
plateaued or decreased slightly (Tables 4 and 5). Thus,
up to the age of 70 years, age provided an independent
element of risk not captured by BMD. Over a 4-SD
interval of BMD (+1 to )3 SD), the risk of a vertebral
fracture increased approximately 9-fold in men and 12-
fold in women.
Disutility
The cumulative loss of utility (disutility) due to fractures
of different types is shown in Table 6 by age and sex. As
expected, average disutility was greatest in the case of
hip fractures over all ages, intermediate for vertebral
fractures and lower for humeral and Colles’ fracture.
Disutility values were higher in the younger age groups
due to the higher life expectancy and higher population
tariff values. The higher tariff values for the younger
healthy population and the use of a multiplier to
compute disutility mean that the absolute (rather than
Table 2 Incidence of all
morphometric and clinically
evident vertebral fractures and
the first morphometric and
clinical fracture (per 100,000
per year) by age in men and
women
Age range (years) Any fracture First fracture Ratio (%)
Morphometric Clinical Morphometric Clinical Clinical/
morphometric
Men Women Men Women Men Women Men Women Men Women
50–54 365 874 153 190 244 577 81 104 33 19
55–59 462 1,164 193 253 311 762 111 148 36 20
60–64 592 1,562 248 339 392 1,021 155 215 39 21
65–69 767 2,115 322 459 511 1,376 215 303 42 22
70–74 1,011 2,891 424 628 666 1,880 296 422 44 23
75–79 1,348 3,986 566 865 888 2,583 407 599 46 23
80–84 1,820 5,544 744 1,204 1,191 3,574 562 844 47 24
85–89 2,485 7,776 1,043 1,688 1,613 4,995 777 1,184 48 24
Table 3 Average 10-year probability (%) of vertebral fracture
according to age
Age (years) Morphometric
spine fracture
Clinical spine
fracture
Men Women Men Women
50 2.9 7.2 1.1 1.4
55 3.7 9.4 1.5 2.0
60 4.6 12.3 1.9 2.8
65 5.6 15.9 2.5 3.8
70 6.8 20.1 3.2 5.1
75 7.8 24.2 3.8 6.4
80 8.5 26.8 4.2 7.4
85 8.4 26.7 4.3 7.5
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proportional) utility loss after fracture is higher in
younger individuals. The consideration of all vertebral
fractures rather than clinical spine fractures alone de-
creased the average disutility of vertebral fractures by
15–30% depending on age. At the age of 50 years, a
clinical spine fracture incurred a disutility of 62% of that
for a hip fracture in men and women, and was sub-
stantially higher than the loss incurred from humeral
fractures by 63%.
The overall burden of vertebral fracture is compared
with incidence in Table 7. In men at the age of 50 years,
clinical fractures accounted for 18% of osteoporotic
fractures between the ages of 50 and 55 years, but for
51% of the total morbidity. With advancing age the
morbidity from clinical vertebral fractures exceeded that
for hip fracture until after the age of 64 years. When
morphometric fractures are considered these comprised,
as expected, a higher proportion of the total number of
fractures, and because of the additional consequences
for morbidity, the population morbidity from morpho-
metric spinal fractures exceeded that of hip fracture until
after the age of 75 years.
The results were qualitatively similar for women ex-
cept where morphometric fractures are concerned. These
accounted for a greater proportion of the total number
of fractures since a greater number of morphometric
Fig. 1 Ten-year probabilities
(%) of a morphometric or
clinical vertebral fracture in
men and women by T-score and
age
Table 4 Ten-year probability of vertebral fracture according to age
and T-score at the femoral neck in men
T-score (SD units)
Age (years) +1 +0.5 0 )0.5 )1.0 )1.5 )2.0 )2.5 )3.0 )4.0
(a) Morphometric
45 0.7 0.9 1.3 1.8 2.4 3.4 4.6 6.4 8.7 16.1
50 0.8 1.1 1.5 2.1 2.9 4.0 5.6 7.8 10.7 19.9
55 0.9 1.2 1.7 2.4 3.4 4.7 6.6 9.2 12.8 24.0
60 1.1 1.5 2.1 2.9 3.9 5.4 7.3 9.9 13.3 23.5
65 1.5 2.0 2.6 3.5 4.6 6.2 8.1 10.7 14.1 23.8
70 1.5 2.0 2.7 3.7 5.1 6.9 9.3 12.6 16.8 28.9
75 1.4 1.9 2.7 3.8 5.3 7.4 10.3 14.1 19.3 34.0
80 1.6 2.2 2.9 3.9 5.3 7.1 9.5 12.7 16.8 28.1
85 1.7 2.2 2.9 3.8 4.9 6.4 8.4 10.8 14.0 22.6
(b) Clinical
45 0.2 0.3 0.4 0.6 0.8 1.1 1.5 2.1 3.0 5.6
50 0.3 0.4 0.5 0.8 1.1 1.5 2.1 2.9 4.0 7.7
55 0.3 0.5 0.7 0.9 1.3 1.9 2.7 3.7 5.3 10.3
60 0.5 0.7 0.9 1.2 1.7 2.3 3.1 4.3 5.8 10.7
65 0.7 0.9 1.2 1.6 2.1 2.8 3.7 4.9 6.5 11.4
70 0.7 0.9 1.3 1.7 2.4 3.2 4.4 6.0 8.1 14.7
75 0.7 0.9 1.3 1.8 2.5 3.6 5.0 7.0 9.7 18.3
80 0.8 1.1 1.4 1.9 2.6 3.5 4.8 6.4 8.6 15.2
85 0.9 1.1 1.4 1.9 2.5 3.2 4.2 5.5 7.2 12.2
Table 5 Ten-year probability of vertebral fracture according to age
and T-score at the femoral neck in women
T-score (SD units)
Age (years) +1 +0.5 0 )0.5 )1.0 )1.5 )2.0 )2.5 )3.0 )4.0
(a) Morphometric
45 2.1 2.7 3.6 4.6 6.0 7.8 10.1 12.9 16.6 26.7
50 2.2 3.0 3.9 5.2 6.8 9.0 11.8 15.3 19.9 32.5
55 2.3 3.1 4.1 5.5 7.5 10.0 13.3 17.6 23.2 38.5
60 2.6 3.6 4.8 6.4 8.6 11.5 15.1 19.9 25.9 42.2
65 3.1 4.2 5.6 7.4 9.9 13.1 17.2 22.3 28.9 45.9
70 3.0 4.2 5.7 7.7 10.4 14.0 18.7 24.6 32.1 51.3
75 2.7 3.8 5.3 7.4 10.2 14.1 19.1 25.6 33.8 54.5
80 2.8 3.9 5.4 7.4 10.2 14.0 18.8 24.9 32.6 51.6
85 2.6 3.6 5.0 6.8 9.2 12.5 16.7 22.0 28.7 45.4
(b) Clinical
45 0.4 0.5 0.6 0.8 1.1 1.4 1.9 2.4 3.2 5.4
50 0.4 0.6 0.8 1.0 1.4 1.8 2.4 3.2 4.2 7.4
55 0.5 0.6 0.9 1.2 1.6 2.2 3.0 4.0 5.4 9.7
60 0.6 0.8 1.1 1.4 1.9 2.6 3.5 4.7 6.4 11.4
65 0.7 1.0 1.3 1.7 2.3 3.1 4.2 5.6 7.5 13.1
70 0.7 1.0 1.3 1.8 2.5 3.5 4.7 6.4 8.7 15.7
75 0.7 0.9 1.3 1.8 2.5 3.5 4.9 6.8 9.5 17.8
80 0.7 1.0 1.3 1.9 2.6 3.6 4.9 6.8 9.3 17.3
85 0.7 0.9 1.3 1.7 2.3 3.2 4.4 6.0 8.2 14.9
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fractures were not clinically apparent. The disutility
occasioned by morphometric deformities outstripped
that resulting from hip fracture, except from the age of
80 years onwards.
Discussion
In this paper we have characterised the risks and burden
of vertebral fracture in Sweden using two definitions of
vertebral fracture. The first is a clinically overt fracture
from which we have previously made estimates for
incidence and burden, albeit with different utility values
[1]. In the present paper we additionally evaluated
morphometric fractures, which include those vertebral
deformities that do not come to clinical attention. The
reason they are included is that they may still be of
clinical significance. Firstly, they are of prognostic
significance in that the risk of further fractures is
significantly increased [4, 29]. Thus, they are useful to
consider in a case-finding strategy, for which purpose
information on fracture probability is required. A sec-
ond reason is that morphometric deformities not coming
to clinical attention are not without symptoms [2, 3]. It is
difficult to be sure to what extent the decrement in
quality of life associated with a clinically silent fracture
is related to the fracture itself or to co-existing mor-
bidity. For this reason we chose relatively conservative
assumptions concerning the ongoing morbidity, so that
the impact of their consideration is relatively modest in
men. In women, nearly twice as many vertebral defor-
mities are clinically covert than in men, so that the im-
pact even of conservative estimates on disutility of non-
clinical fractures is quantitatively greater.
In this paper we describe 10-year probabilities for
vertebral fractures. Such data require documentation of
the first fracture at a particular site. Second or sub-
sequent fractures are common, particularly at the spine
[10]. The overestimate from unadjusted data on vertebral
fracture incidence is approximately 36% (see Table 2), so
that the use of unadjusted data overestimates long-term
risks. For this reason we used the incidence of first
fracture. By contrast, long-term risks are underestimated
when no account is taken of future mortality. For the 10-
year time span that we used in this paper, the effect is
small, but the data are nevertheless adjusted.
It should be noted that the estimates of risk that we
provide are modelled from measurements made at the
femoral neck with BMD using DXA. The probabilities
computed would differ from those derived from mea-
surements made with other techniques or with the same
technique, but at other sites. We also assume that the
increase in risk of fracture is the same in women as in
men. Though the data are scanty, the available evidence
would suggest that this is so [18, 19, 20, 21, 22].
A further limitation of these estimates is that they
apply to a Swedish population and used data from
Malmo, Sweden. For fractures other than vertebral
fractures, data from Malmo appear to be representative
for Sweden [10, 30]. A strength of the use of Swedish
data is the accuracy of information on fracture rates and
on mortality. A disadvantage is that fracture rates are
Table 6 Disutility for different fracture types by age adjusted for
the population tariffs using a discount of 10% per annum
Type of
fracture
Age range (years)
50–54 55–59 60–64 65–69 70–74 75–79 80–84 85–89
(a) Men
Morphometric
spine
0.877 0.800 0.757 0.713 0.714 0.557 0.420 0.350
Clinical spine 1.026 0.938 0.895 0.850 0.768 0.687 0.538 0.472
Humerus 0.383 0.353 0.339 0.327 0.301 0.277 0.228 0.212
Hip 1.643 1.491 1.402 1.304 1.148 0.980 0.701 0.943
Forearm 0.010 0.009 0.009 0.009 0.008 0.007 0.005 0.005
(b) Women
Morphometric
spine
0.857 0.640 0.621 0.733 0.622 0.545 0.444 0.321
Clinical spine 1.053 0.751 0.734 0.917 0.790 0.706 0.594 0.460
Humerus 0.392 0.282 0.278 0.349 0.305 0.279 0.243 0.200
Hip 1.692 1.193 1.149 1.430 1.202 1.041 0.829 0.570
Forearm 0.011 0.007 0.007 0.009 0.008 0.007 0.006 0.004
Table 7 The proportion of
fractures (%) due to vertebral,
hip and other osteoporotic
fractures by age, sex and the
definition of vertebral fracture
(left hand panels) compared
with the burden (disutility
adjusted incidence; right hand
panels)
Sex Definition of
vertebral fracture
Site of
fracture
Age range (years)
Incidence based Disutility based
50–54 60–64 70–74 80–84 50–54 60–64 70–74 80–84
M Clinical Spine 18 22 17 10 51 44 30 18
Hip 5 12 20 27 22 37 52 67
Other 77 66 63 63 27 19 18 15
M Morphometric Spine 34 40 33 22 68 61 48 32
Hip 4 9 16 23 15 26 38 56
Other 62 51 51 55 17 13 16 12
F Clinical Spine 17 21 17 13 48 40 25 17
Hip 4 11 22 37 16 33 50 65
Other 79 68 61 50 36 27 25 18
F Morphometric Spine 49 55 48 41 77 72 55 41
Hip 2 6 14 25 7 15 30 46
Other 49 39 38 34 16 13 15 13
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high and mortality is low compared to many other re-
gions of the world. Thus, the probabilities we report are
not necessarily applicable to other areas, particularly in
the developing world. In addition, the pattern of
probability with age may differ between countries.
Short-term risks increase progressively with age until the
short-term risk of death outstrips the fracture risk.
Thereafter, the probability falls with age. For 10-year
probabilities this break point occurred at the age of 75 to
85 years, but would occur sooner in countries with a
higher mortality.
A significant finding from the present study is the
high morbidity consequences of vertebral fractures
arising from the high utility losses. Quality of life was
measured throughout the 1st year following a clinical
vertebral fracture to assess quality-adjusted life years
(QALYs). With this technique health states are valued
between 0 (death or the worst health state imaginable)
and 1 (perfect health). The loss of utility in the 1st year
after vertebral fracture was 37% that of an individual in
perfect health. This estimate is markedly greater than
those previously used by ourselves and by the National
Osteoporosis Foundation [1, 26]. These estimates (5%
utility loss) were based on expert opinion in the absence
of empirical data. Subsequent studies, including our
own, have shown these losses to be seriously underesti-
mated [5, 6, 7, 8]. The validity of our findings is further
supported by the health state values we derived in the
same study for hip fracture and for forearm fracture,
which are very close to other empirical estimates [31, 32,
33].
It may be relevant that these health states were taken
from patients originally attending the orthopaedic
department and may not be representative of all clini-
cally overt fractures. Comparison of the incidence rates
over all clinically evident fractures (Malmo 1993–1994)
and hospitalised fractures (Swedish patient register
1996) suggests that approximately 25% of men and
women are hospitalised. In the patients in whom we
assessed quality of life, 42% were hospitalised, suggest-
ing that bias cannot be excluded.
The high morbidity from clinical vertebral fractures is
most marked in the first 6 months after the fracture
event and thereafter attenuated with time similar to
observations of Tosteson et al. [8]. Nevertheless, the
utility loss in the 1st year was at least as great as that
noted for hip fracture. In subsequent years we assumed
that utility loss diminished in keeping with other
observations that studied patients well after fracture
events [8, 25]. Thus, when utility loss was cumulated
over remaining life-time, disutility was less than for hip
fracture, since the impairment of quality of life is more
marked in 2nd and subsequent years for hip fracture
compared to clinical vertebral fracture. At the age of
50 years the disutility from clinical vertebral fracture
was 1.053 in women compared with 1.692 for hip frac-
ture (see Table 6). Thus, a clinical vertebral fracture
occasions 62% of the morbidity expected from a hip
fracture at that age. In an earlier study where the NOF
estimates of utility loss were used [26], we estimated that
the utility loss from a clinical vertebral fracture was only
24% that of a hip fracture [1].
Greater uncertainties surround the disutility associ-
ated with clinically silent fractures, since a greater
proportion of the utility loss computed may be related
to pre-existing comorbidity compared to clinical frac-
tures. The disutility assumed is, however, modest and
has a small impact on the expected disutility at any
age. For example, in women aged 50 years the average
utility loss from a clinical spine fracture was 1.053 and
0.857 for all vertebral fractures combined (see Table 6).
Since costs of asymptomatic morphometric fractures
are also likely to be lower than for clinical fractures,
the consideration of all fractures or clinical fractures in
health economic analysis is likely to have little impact
on estimates of cost effectiveness and thus on inter-
vention thresholds.
The undervaluation of vertebral fracture morbidity
compared to that of a hip fracture has consequences for
practice guidelines that are based on health economic
assessment. Hip fractures occur most often in advanced
age and intervention becomes more cost-effective,
therefore, with advancing age. Vertebral fractures (and
other osteoporotic fractures) by contrast occur earlier in
the natural history of osteoporosis. The omission of
these fractures or undervaluation of the morbidity in
turn undervalues the cost-effectiveness of interventions,
particularly in younger patients with osteoporosis. Thus,
higher intervention thresholds arise if health economic
estimates are made on hip fracture risk alone, particu-
larly in younger individuals.
We conclude that the morbidity arising from verte-
bral fractures has been considerably underestimated
using values derived from expert opinion. Empirical
data suggest a very substantial impact of clinical verte-
bral fractures that incur a disability that is approxi-
mately 62% of that incurred by a hip fracture over the
remaining lifetime of individuals. The large societal
impact, particularly in mid-life, needs to be accounted
for in health economic strategies for osteoporosis.
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